BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27511631)

  • 21. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Devil in the detail of newborn screening for cystic fibrosis.
    Doull I
    Arch Dis Child; 2019 Oct; 104(10):938-940. PubMed ID: 30389674
    [No Abstract]   [Full Text] [Related]  

  • 23. Ethnicity impacts the cystic fibrosis diagnosis: A note of caution.
    Bosch B; Bilton D; Sosnay P; Raraigh KS; Mak DYF; Ishiguro H; Gulmans V; Thomas M; Cuppens H; Amaral M; De Boeck K
    J Cyst Fibros; 2017 Jul; 16(4):488-491. PubMed ID: 28233695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misdiagnosis of cystic fibrosis based on transient pancreatic insufficiency and elevated sweat chloride.
    Bagheri-Behrouzi A; Steiß JO; Zimmer KP; Nährlich L
    Klin Padiatr; 2015 Mar; 227(2):96-7. PubMed ID: 25751685
    [No Abstract]   [Full Text] [Related]  

  • 25. Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition.
    Southern KW; Barben J; Gartner S; Munck A; Castellani C; Mayell SJ; Davies JC; Winters V; Murphy J; Salinas D; McColley SA; Ren CL; Farrell PM
    J Cyst Fibros; 2019 Nov; 18(6):778-780. PubMed ID: 31027826
    [No Abstract]   [Full Text] [Related]  

  • 26. Cystic Fibrosis Diagnosis and Newborn Screening.
    Rosenfeld M; Sontag MK; Ren CL
    Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Question 7: For an infant with an equivocal sweat chloride following newborn screening, how likely is a diagnosis of cystic fibrosis?
    Groves T; Robinson P; Fitzgerald DA
    Paediatr Respir Rev; 2016 Sep; 20():48-50. PubMed ID: 26724140
    [No Abstract]   [Full Text] [Related]  

  • 28. New cystic fibrosis genetic tests bring hope and dilemmas.
    Arnold C
    Lancet Respir Med; 2014 Jan; 2(1):30. PubMed ID: 24461897
    [No Abstract]   [Full Text] [Related]  

  • 29. [Management of infants whose diagnosis is inconclusive at neonatal screening for cystic fibrosis].
    Sermet-Gaudelus I; Brouard J; Audrézet MP; Couderc Kohen L; Weiss L; Wizla N; Vrielynck S; LLerena K; Le Bourgeois M; Deneuville E; Remus N; Nguyen-Khoa T; Raynal C; Roussey M; Girodon E
    Arch Pediatr; 2017 Apr; 24(4):401-414. PubMed ID: 28258861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
    Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
    Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
    [No Abstract]   [Full Text] [Related]  

  • 31. When CFSPID becomes CF.
    Ginsburg D; Wee CP; Reyes MC; Brewington JJ; Salinas DB
    J Cyst Fibros; 2022 Jan; 21(1):e23-e27. PubMed ID: 34756682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?
    Castellani C; Massie J
    Eur Respir J; 2014 Jan; 43(1):20-3. PubMed ID: 24381320
    [No Abstract]   [Full Text] [Related]  

  • 33. Normal sweat chloride test does not rule out cystic fibrosis.
    Başaran AE; Karataş-Torun N; Maslak İC; Bingöl A; Alper ÖM
    Turk J Pediatr; 2017; 59(1):68-70. PubMed ID: 29168366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory tests for the diagnosis of cystic fibrosis.
    Wang L; Freedman SD
    Am J Clin Pathol; 2002 Jun; 117 Suppl():S109-15. PubMed ID: 14569807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis.
    Keating CL; Liu X; Dimango EA
    Chest; 2010 May; 137(5):1157-63. PubMed ID: 19965956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis screen-positive neonates with one pathogenic variant still warrant sweat testing.
    Rock MJ; Baker M; Farrell PM
    Pediatr Pulmonol; 2023 Nov; 58(11):3342-3345. PubMed ID: 37503874
    [No Abstract]   [Full Text] [Related]  

  • 37. The importance of sweat testing for older siblings of patients with cystic fibrosis identified by newborn screening.
    Munck A; Houssin E; Roussey M
    J Pediatr; 2009 Dec; 155(6):928-930.e1. PubMed ID: 19914431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloride and sodium ion concentrations in saliva and sweat as a method to diagnose cystic fibrosis.
    Gonçalves AC; Marson FAL; Mendonça RMH; Bertuzzo CS; Paschoal IA; Ribeiro JD; Ribeiro AF; Levy CE
    J Pediatr (Rio J); 2019; 95(4):443-450. PubMed ID: 29782810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First case of cystic fibrosis in Greenland - diagnosed by neonatal screening.
    M S; A K; M D
    J Cyst Fibros; 2020 May; 19(3):e14-e15. PubMed ID: 32089517
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype.
    McKone EF; Velentgas P; Swenson AJ; Goss CH
    J Cyst Fibros; 2015 Sep; 14(5):580-6. PubMed ID: 25660278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.